MicroTransponder
12147 Leuders
Suite 227
Dallas
Texas
75230
United States
Website: http://www.microtransponder.com/
Email: info@microtransponder.com
10 articles about MicroTransponder
-
MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
1/31/2023
MicroTransponder®, Inc. announces that the Centers for Medicare and Medicaid Services awarded the Vivistim® Paired VNS™ System transitional pass-through status, expanding access to Medicare beneficiaries who are ischemic stroke survivors interested in using the breakthrough technology to help improve their hand and arm mobility.
-
MicroTransponder Completes $73M Series E Financing
9/21/2022
MicroTransponder, Inc. positions for continued strategic growth, having finalized its oversubscribed $73 million Series E funding round and named Prashant Rawat chief operating officer (COO).
-
Funding for life sciences companies picked up this week as investors pumped new money into firms developing treatments for spinal muscular atrophy (SMA), immuno-oncology, allergies and rare diseases.
-
MicroTransponder Raises $53M, Appoints New CEO
6/20/2022
MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners, a multi-stage investment firm.
-
First Commercial Vivistim Patient Set to Begin Paired VNS Therapy for Improved Upper Limb Function Post Stroke
5/11/2022
MicroTransponder®, Inc. reached a milestone Tuesday with the first commercial use of its Vivistim® Paired VNS™ System.
-
Vivistim Clinical Trial Team Wins 2022 American Heart Association's Paul Dudley White International Scholar Award
2/15/2022
The Vivistim clinical trial team won the 2022 Paul Dudley White International Scholar Award for submitting the highest-ranked abstract from the United Kingdom to the American Heart Association's International Stroke Conference 2022, according to MicroTransponder®, Inc.
-
Vivistim Paired VNS System Awarded Gold Electrode Award for Best New Product by Neurotech Reports
12/7/2021
MicroTransponder® Inc. announced that its Vivistim® Paired VNS™ System won the Neurotech Reports Gold Electrode Award for best new product.
-
MicroTransponder® Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
8/31/2021
MicroTransponder, Inc. today announced United States Food and Drug Administration (FDA) Premarket Approval of the Vivistim Paired VNS™ System, which significantly improves the effectiveness of rehabilitation therapy for stroke survivors with moderate to severe upper extremity impairment six months after stroke.
-
Positive Stroke Rehabilitation Clinical Trial Results for the Vivistim® Paired VNS™ System Published in The Lancet
4/22/2021
MicroTransponder Inc., today announced that the pivotal clinical trial results for the Company's investigational Vivistim® Paired Vagus Nerve Stimulation (VNS) System have been published in The Lancet.
-
MicroTransponder Raises $2 Million and Reports Positive Tinnitus Clinical Trial
7/6/2012